MERCORELLI, BEATRICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.818
EU - Europa 321
AS - Asia 221
SA - Sud America 6
AF - Africa 4
Totale 3.370
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.814
CN - Cina 186
IT - Italia 104
FI - Finlandia 70
DE - Germania 43
SE - Svezia 37
GB - Regno Unito 22
UA - Ucraina 21
VN - Vietnam 16
IN - India 13
FR - Francia 8
IE - Irlanda 7
CA - Canada 4
BR - Brasile 3
GH - Ghana 3
KR - Corea 3
SI - Slovenia 3
CL - Cile 2
BO - Bolivia 1
GR - Grecia 1
IL - Israele 1
JP - Giappone 1
MA - Marocco 1
NL - Olanda 1
PL - Polonia 1
PT - Portogallo 1
RO - Romania 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 3.370
Salva come PNG Salva come JPEG
Città #
Fairfield 514
Woodbridge 264
Ashburn 260
Chandler 232
Houston 226
Cambridge 195
Seattle 193
Ann Arbor 190
Wilmington 144
San Diego 51
Helsinki 47
Jacksonville 47
Beijing 45
Princeton 43
Roxbury 31
Medford 28
Boardman 26
Guangzhou 26
Dearborn 25
Columbus 22
Des Moines 20
Nanjing 20
Padova 17
Dong Ket 15
Shanghai 14
Shenyang 12
Pune 10
Dublin 7
Kharkiv 7
Norwalk 7
Cagliari 6
Camponogara 6
New York 6
Jiaxing 5
London 5
Milan 5
Nanchang 5
Vicenza 5
Buffalo 4
Crotone 4
Falls Church 4
Hefei 4
Nürnberg 4
Washington 4
Accra 3
Jinan 3
Los Angeles 3
Redwood City 3
Aversa 2
Belo Horizonte 2
Changsha 2
Correggio 2
Dro 2
Falkenstein 2
Islington 2
Kilburn 2
Kunming 2
Las Vegas 2
Ogden 2
Portland 2
Tappahannock 2
Tianjin 2
Torino 2
Wuhan 2
Agordo 1
Aprilia 1
Auburn Hills 1
Berlin 1
Bhopal 1
Bolzano 1
Borås 1
Boston 1
Bucharest 1
Chaoyang 1
Chengdu 1
Chicago 1
Chiswick 1
Clearwater 1
Cochabamba 1
Desio 1
Edinburgh 1
Frankfurt am Main 1
Fuzhou 1
Hangzhou 1
Hanoi 1
Hebei 1
Irving 1
Lappeenranta 1
Ljubljana 1
Miami 1
Nantong 1
Perugia 1
Rabat 1
Rockville 1
Rome 1
San Francisco 1
Santa Clara 1
Santiago 1
Shaoxing 1
St Petersburg 1
Totale 2.885
Salva come PNG Salva come JPEG
Nome #
4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling 183
A Broad anti-influenza hybrid small molecule that potently disrupts the interaction of polymerase acidic protein-basic protein 1 (PA-PB1) subunits 147
Antiviral strategies against influenza virus: towards new therapeutic approaches. 144
Drug Repurposing for Viral Infectious Diseases: How Far Are We? 142
Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus Replication 136
Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives. 135
Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase. 134
Role of homodimerization of human cytomegalovirus DNA polymerase accessory protein UL44 in origin-dependent DNA replication in cells. 134
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 130
The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity 128
Design, synthesis, and evaluation of WC5 analogues as inhibitors of human cytomegalovirus Immediate-Early 2 protein, a promising target for anti-HCMV treatment. 119
Optimization of Small-Molecule Inhibitors of Influenza Virus Polymerase: From Thiophene-3-Carboxamide to Polyamido Scaffolds 115
The 6-Aminoquinolone WC5 Inhibits Human Cytomegalovirus Replication at an Early Stage by Interfering with the Transactivating Activity of Viral Immediate-Early 2 Protein 112
A point mutation in a herpesvirus polymerase determines neuropathogenicity. 112
The 6-Aminoquinolone WC5 Inhibits Different Functions of the Immediate-Early 2 (IE2) Protein of Human Cytomegalovirus That Are Essential for Viral Replication. 111
Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly. 111
Approaches for the generation of new anti-cytomegalovirus agents: identification of protein-protein interaction inhibitors and compounds against the HCMV IE2 protein. 100
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 97
Human cytomegalovirus DNA replication: antiviral targets and drugs. 92
Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein 92
The Human Cytomegalovirus DNA Polymerase Processivity Factor UL44 is Modified by SUMO in a DNA-dependent manner 91
Binding parameters and thermodynamics of the interaction of the human cytomegalovirus DNA polymerase accessory protein, UL44, with DNA: implications for the processivity mechanism 89
A 6-Aminoquinolone Compound, WC5, with Potent and Selective Anti-Human Cytomegalovirus Activity 86
Drug Repurposing Campaigns for Human Cytomegalovirus Identify a Natural Compound Targeting the Immediate-Early 2 (IE2) Protein: A Comment on "The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts" 83
A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth 80
The antifungal drug isavuconazole inhibits the replication of human cytomegalovirus (HCMV) and acts synergistically with anti-HCMV drugs 73
Sulfated Derivatives of Escherichia coli K5 Polysaccharide are Potent Inhibitors of Human Cytomegalovirus. 70
Human Cytomegalovirus Inhibitor AL18 Also Possesses Activity against Influenza A and B Viruses. 64
The Clinically Approved Antifungal Drug Posaconazole Inhibits Human Cytomegalovirus Replication 57
The dimeric form of hpv16 e6 is crucial to drive yap/taz upregulation through the targeting of hscrib 53
Divide et impera: An In Silico Screening Targeting HCMV ppUL44 Processivity Factor Homodimerization Identifies Small Molecules Inhibiting Viral Replication 46
Indomethacin-based PROTACs as pan-coronavirus antiviral agents 44
Targeted disruption of e6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against hpv-transformed cancer cells 31
Caratterizzazione di nuovi composti antivirali contro il citomegalovirus umano e studio del meccanismo di neuropatogenocità nel herpesvirus equino di tipo 1 29
Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization 23
Composition and methods for the treatment of pathological condition associated with cytomegalovirus infection. 22
A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells 15
Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy In Vivo 13
Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability 1
Human neural progenitor cell models to study the antiviral effects and neuroprotective potential of approved and investigational human cytomegalovirus inhibitors 1
Totale 3.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.868
article - articoli 11.224
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 114
selected - selezionate 0
volume - volumi 349
Totale 23.555
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019187 0 0 0 0 0 0 0 0 0 0 103 84
2019/2020903 71 26 24 93 114 88 115 104 130 60 54 24
2020/2021534 30 29 20 50 19 24 26 41 75 36 77 107
2021/2022589 10 70 90 51 47 29 34 64 13 18 59 104
2022/2023510 86 55 22 48 91 64 4 40 49 17 32 2
2023/2024331 7 51 62 26 40 33 45 27 8 32 0 0
Totale 3.445